Χώρα: Ιρλανδία
Γλώσσα: Αγγλικά
Πηγή: HPRA (Health Products Regulatory Authority)
SALMETEROL XINAFOATE; Fluticasone propionate
Clonmel Healthcare Ltd
R03AK06
SALMETEROL XINAFOATE; Fluticasone propionate
50/500 microgram(s)
Inhalation powder, pre-dispensed
salmeterol and fluticasone
Marketed
2021-03-05
Page 1 of 9 PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SAMETEC AIRMASTER 50 MICROGRAM/100 MICROGRAM/ DOSE INHALATION POWDER, PRE-DISPENSED SAMETEC AIRMASTER 50 MICROGRAM/250 MICROGRAM/ DOSE INHALATION POWDER, PRE-DISPENSED SAMETEC AIRMASTER 50 MICROGRAM/500 MICROGRAM/ DOSE INHALATION POWDER, PRE-DISPENSED salmeterol/fluticasone propionate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Sametec Airmaster is and what it is used for 2. What you need to know before you use Sametec Airmaster 3. How to use Sametec Airmaster 4. Possible side effects 5. How to store Sametec Airmaster 6. Contents of the pack and other information 1. WHAT SAMETEC AIRMASTER IS AND WHAT IT IS USED FOR Sametec Airmaster contains two medicines, salmeterol and fluticasone propionate: • Salmeterol is a long-acting bronchodilator. Bronchodilators help the airways in the lungs to stay open. This makes it easier for air to get in and out. The effects last for at least 12 hours. • Fluticasone propionate is a corticosteroid which reduces swelling and irritation in the lungs. SAMETEC AIRMASTER IS USED TO TREAT ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER. The doctor has prescribed this medicine to help prevent breathing problems such as: • Asthma or • Chronic Obstructive Pulmonary Disease (COPD). Sametec Airmaster, at a dose of 50/500 micrograms, reduces the number of flare ups of COPD symptoms. You must use Sametec Airmaster everyday as directed by your doctor. This will make sure that it w Διαβάστε το πλήρες έγγραφο
Health Products Regulatory Authority 08 October 2021 CRN00CD5C Page 1 of 16 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sametec Airmaster 50 microgram/ 500 microgram/ dose, inhalation powder, pre-dispensed 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 43 micrograms of salmeterol (as salmeterol xinafoate) and 432 micrograms of fluticasone propionate. This corresponds to a pre-metered dose of 50 micrograms of salmeterol (as salmeterol xinafoate) and 500 micrograms fluticasone propionate. Excipient with known effect Each delivered dose contains approximately 13 milligrams of lactose (as monohydrate). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Inhalation powder, pre-dispensed. Moulded plastic device containing a foil strip with 60 regularly placed blisters. Each blister contains pre-dispensed dose of white to off white inhalation powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Sametec Airmaster is indicated in adults and adolescents 12 years of age and older. _ASTHMA_ Sametec Airmaster is indicated in the regular treatment of asthma where use of a combination product (long- acting β 2 agonist and inhaled corticosteroid) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting β 2 agonist or - patients already adequately controlled on both inhaled corticosteroid and long-acting β 2 agonist Note: Sametec Airmaster 50 microgram /100 microgram strength is not appropriate in adults and children with severe asthma. _CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)_ Sametec Airmaster is indicated for the symptomatic treatment of patients with COPD, with a FEV 1 < 60 % predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Patients are to be made aware that Sametec Airmaster must Διαβάστε το πλήρες έγγραφο